Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Abstract Session

Hematologic and Oncologic Associated Rheumatic Syndromes
General Topic: Clinical Science

28T19: Abstracts: Immunological Complications of Medical Therapy (1728–1733)

Tuesday, October 28, 2025
10:00 AM - 11:30 AM Central Time
Location: S102
CE: 0.00

Non-CME In Person On Demand

    Abstract Moderator(s)

  • Vibeke Strand, MD, FACP, MACR

    Adjunct Clinical Professor
    Stanford University School of Medicine, Palo Alto CA
    Portola Valley, California, United States

    Disclosure information not submitted.

  • VS

    Vanessa Smith, MD, PhD

    Ghent University Hospital
    Gent, Belgium

    Disclosure information not submitted.

Please note: This session is not eligible for CME Credits.

Presentations:

  • 10:00 AM - 10:15 AM Central Time
    Longitudinal Proteomic Signatures for Prediction of Immune-Related Adverse Events during Immune Checkpoint Inhibitors therapy: A Machine Learning-Guided Prospective Biomarker Discovery Study

    Presenting Author: Huaxia Yang, MD – Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

  • 10:15 AM - 10:30 AM Central Time
    The ERIN Registry: Real-World Data on Rheumatic Immune-Related Adverse Events from Immune Checkpoint Inhibitor Therapy

    Presenting Author: Didzis Gailis, MD – LMU University Hospital

  • 10:30 AM - 10:45 AM Central Time
    Oral glucocorticoid treatment for checkpoint inhibitor associated inflammatory arthritis do not affect progression free survival: a RADIOS Registry cohort study

    Presenting Author: Deanna Jannat-Khah, MPH, DrPH – Hospital For Special Surgery

  • 10:45 AM - 11:00 AM Central Time
    A Post-marketing Analysis of Autoimmune Toxicities Following Chimeric Antigen Receptor T-cell Therapy Using the FDA Adverse Event Reporting System

    Presenting Author: Malvika Gupta, MD (she/her/hers) – Mayo Clinic

  • 11:00 AM - 11:15 AM Central Time
    Incidence of Flares in Pre-existing Rheumatologic Diseases Among Patients with Solid Tumors Undergoing Cancer Immunotherapy: A Systematic Review and Meta-analysis

    Presenting Author: Takemichi Matsui, MD – Icahn School of Medicine at Mount Sinai

  • 11:15 AM - 11:30 AM Central Time
    Risk factors for the development of immune checkpoint inhibitor-related adverse events, including rheumatology-related presentations

    Presenting Author: Adela Francis-Malave, BS (she/her/hers) – University of Pennsylvania, Perelman School of Medicine